2013-02-14 14:29:46 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to produce reports on a company's attractiveness to long-term investors.

Ilhavo, Portugal — SADIF Investment Analytics, announces a new summary due diligence report covering the following companies:

Report Summary for: PT Summarecon Agung Tbk. is an average quality company with a neutral outlook. PT Summarecon Agung Tbk. has strong business growth and is run by efficient management. The trend in PT Summarecon Agung Tbk. fair value exchange rate against its closest rated-competitor, PT Ciputra Surya Tbk, has been depreciating over the past 2 weeks. When compared to its closest competitor, PT Summarecon Agung Tbk. shows similar undervaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-49-SMRA

Report Summary for:

PT Selamat Sempurna Tbk is an above average quality company with a neutral outlook. PT Selamat Sempurna Tbk has medium business growth and is run by efficient management. The trend in PT Selamat Sempurna Tbk fair value exchange rate against its closest rated-competitor, PT Prima Alloy Steel Universal Tbk, has been depreciating over the past 2 weeks. When compared to its closest competitor, PT Selamat Sempurna Tbk shows greater undervaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-49-SMSM

Report Summary for: PT Suparma Tbk is a below average quality company with a neutral outlook. PT Suparma Tbk has medium business growth and is run by mediocre management. The trend in PT Suparma Tbk fair value exchange rate against its closest rated-competitor, PT Surabaya Agung I P & K Tbk, has been appreciating over the past 2 weeks. When compared to its closest competitor, PT Suparma Tbk shows similar overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-49-SPMA


About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering twenty four different markets and over 18,000 companies. The StockMarks™ system is based on proven investment principles and is designed to drive long-term shareholder returns.